This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The use of specialty medicine has grown rapidly in recent decades, fueling parallel growth in the number of specialtypharmacies that serve patients who are prescribed specialty medications. Results of this work were published in the Journal of Managed Care & SpecialtyPharmacy in October 2022.
While SaveOnSP is the nominal target of the lawsuit, it claims to expose one of the failings in the US health insurance sector, adding fire to an increasingly heated exchange between pharma manufacturers and pharmacy benefit managers (PBMs), which have blamed each other for high medicine prices in the US.
However, its effectiveness and versatility come at a cost, which leaves many people looking to their insurance provider for help. Many health insurance and Medicare Part D plans will cover Humira, including some from Blue Cross Blue Shield, but it depends on the specific plan. Here’s what you need to know.
Specialty drugs like Dupixent are expensive to produce, and those costs are passed to consumers paying out of pocket. Insurance typically covers Dupixent, but coverage varies by plan and reason for taking. The Blue Cross and Blue Shield Association isn’t a single insurance provider.
But its effectiveness and versatility come at a price that leaves many patients hoping for health insurance coverage. If your private insurance covers Remicade, there might be some caveats involved. Remicade (infliximab) is a tumor necrosis factor (TNF) blocker that’s approved to treat these conditions.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content